---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-322866"
form_type: "8-K"
ticker: "BLCO"
cik: "0001860742"
company_name: "Bausch & Lomb Corp"
filed_at: "2025-12-17T23:59:59+00:00"
generated_at: "2026-05-16T12:56:56.192060+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Bausch + Lomb appoints Eduardo Alfonso, MD and Steven Collis to board, effective Jan 1, 2026

## Summary
- Eduardo C. Alfonso, MD, and Steven H. Collis appointed to Bausch + Lomb board, effective Jan 1, 2026.
- Appointments fill vacancies left by Brett Icahn and Gary Hu who departed in August 2025; board will have 10 directors.
- Both new directors are independent under NYSE and TSX rules; no committee assignments announced.
- Alfonso is a prominent ophthalmologist; Collis is former CEO of AmerisourceBergen (Fortune 10).

## SEC filing metadata
- accession: 0001193125-25-322866
- form_type: 8-K
- ticker: BLCO
- cik: 0001860742
- company_name: Bausch & Lomb Corp
- filed_at: 2025-12-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860742/000119312525322866/0001193125-25-322866-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860742/000119312525322866/d29805d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-322866
- JSON: https://secwatch.observer/filing/0001193125-25-322866.json
- Plain text: https://secwatch.observer/filing/0001193125-25-322866.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.